Jeffrey Spivak, MD
Orthopaedic Surgery of the Spine · New York, NYNPI 1700861168
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $897,224 of the $1,308,973 with a category attached, or 68.5%. Medtronic accounts for 96.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $540,958 and has fallen 94.1% since, to $32,156 in 2025. Among orthopaedic surgery of the spine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $26,179 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1.3M
- Titan Spine, LLC$46K
- Nexus Spine, LLC$215
- Stryker$149
- Zimmer Biomet$122
- Globus Medical$66
- plus $158 from 4 others
What the payments were for
- Royalty or licence$897,22469%
- Food & beverage$1,3620%
- Other$410,38731%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 37 | $1,262,553 |
| Titan Spine, LLC | 2 | $45,711 |
| Nexus Spine, LLC | 2 | $215 |
| Stryker | 1 | $149 |
| Zimmer Biomet | 1 | $122 |
| Globus Medical | 1 | $66 |
| AbbVie | 3 | $63 |
| Johnson & Johnson | 1 | $56 |
| Lilly USA, LLC | 1 | $22 |
| Si-bone, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- nanoLOCK-C$342,569
- nanoLOCK-L$227,610
- ENDOSKELETON TL NANOLOCK SURFACE TECHNOLOGY$124,661
- nanoLOCK$45,711
- Endoskeleton$45,711
- MazorX - Renaissance$305
- PressOn$177
- CASCADIA$149
- Mobi-C$122
How this compares
$1,308,973 in reported general payments places this provider in the 95th percentile of 161 orthopaedic surgery of the spine providers in New York.
See all orthopaedic surgery of the spine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in New York
- Frank SchwabNew York$5.1M
- Han KimNew York$3.9M
- Todd AlbertNew York$2.7M
- Aaron BucklandNew York$1M
- Sheeraz QureshiNew York$828K
- Jeffrey GoldsteinNew York$765K
- Fabien BitanNew York$624K
- Oheneba Boachie-AdjeiNew York$313K
- Harvinder SandhuNew York$266K
- Federico GirardiNew York$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.